In this episode of MD Newsline, Laura Crandon, Founder and President of Touch4Life and a two-time breast cancer survivor, shares her powerful journey from diagnosis to advocacy. Drawing from her lived experience with metastatic breast cancer, Laura highlights critical disparities in breast cancer outcomes—particularly among Black women—and the urgent need for equitable access to screening, testing, and treatment.

She discusses how gaps in clinical trials, biomarker testing, and guideline implementation contribute to poorer outcomes in underserved communities. Laura also explains how Touch4Life is addressing these disparities through education, advocacy, and community-based programs designed to empower individuals to take control of their breast health.

This episode offers valuable insights for healthcare providers, researchers, and advocates seeking to improve equity in cancer care and outcomes.

A Patient Journey That Sparked a Movement
Laura Crandon shares her experience with an initial missed opportunity in screening due to dense breast tissue, leading to an aggressive breast cancer diagnosis and eventual metastasis to the brain. Her journey underscores the importance of self-advocacy, early detection, and personalized treatment.

Understanding Breast Cancer Disparities
Black women face a 41% higher mortality rate from breast cancer and are disproportionately affected by aggressive subtypes like triple-negative breast cancer. Laura highlights how underrepresentation in clinical trials and biodata contributes to inequitable treatment outcomes.

The Role of Biomarker and Genetic Testing
Laura emphasizes the importance of biomarker and genetic testing in guiding personalized cancer treatment. She advocates for increased awareness and access to these tools, particularly in underserved communities.

Touch4Life's Mission and Community Impact
Through initiatives like education programs, advocacy training, and the B-FRESH nutrition program, Touch4Life empowers individuals with knowledge about screening guidelines, family health history, and proactive care strategies.

Engaging Providers and Researchers in Equity Efforts
Laura calls on healthcare providers and researchers to actively address disparities by offering appropriate screenings, recommending clinical trials, and partnering with organizations like Touch4Life to improve patient outcomes.

The "Black Genes Matter" Movement
Laura introduces the "Black Genes Matter" initiative, which promotes awareness of genetics and genomics in breast cancer care. The movement encourages individuals to understand their risk factors and advocate for precision medicine.

Laura Crandon highlights that achieving breast health equity requires collective action—from empowering patients with knowledge to holding healthcare systems accountable. By improving access to screening, increasing representation in research, and embracing personalized medicine, we can work toward more equitable outcomes for all.

• Website: https://mdnewsline.com/
• Newsletter: https://mdnewsline.com/subscribe/

Learn More About Touch4Life:

• https://touch4life.org/